Estrogen uncouples noradrenergic activation of Fos expression in the female rat preoptic area.
The preoptic area of the rat brain is a site at which gonadal steroids act to regulate sexual behaviour and gonadotrophin secretion. The expression of the immediate-early gene product, Fos, in the preoptic area was investigated in conscious ovariectomised, vehicle and estrogen-treated animals which had received an intracerebroventricular (i.c.v.) infusion of noradrenaline, and also in anaesthetised proestrous and ovariectomised rats following electrical stimulation of the brainstem A1 or A2 noradrenergic cell groups. In ovariectomised oil-treated rats, a third ventricular infusion of noradrenaline (45 micrograms) resulted in a significant (P < 0.05) increase in the numbers of Fos-immunoreactive cell nuclei throughout the preoptic area, compared to vehicle controls. In contrast, Fos expression in animals which had received estrogen replacement showed no change in response to i.c.v. noradrenaline compared with saline-treated controls. In anaesthetised, ovariectomised animals electrical stimulation of the A1 cell group resulted in a significant increase (P < 0.05) in Fos-like immunoreactivity compared with sham controls, specifically within the ventral preoptic area whilst stimulation of the A2 cell group had no significant effect. In anaesthetised, proestrous rats receiving electrical stimulation no significant changes in Fos-like immunoreactivity were detected within the preoptic area after either A1 or A2 stimulation compared with paired controls. These results show that noradrenaline-induced Fos expression in the preoptic area is dependent on estrogen status and suggest that the estrogenic regulation of reproductive functions may thus involve altered responses to noradrenaline in sub-populations of preoptic neurones.
Laboratory of Neuroendocrinology, Babraham Institute, Cambridge, UK.
G L
GL
Condé
A E
AE
Herbison
C
C
Fernandez-Galaz
R J
RJ
Bicknell
D000818:Animals; D004558:Electric Stimulation; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007150:Immunohistochemistry; D007276:Injections, Intraventricular; D009638:Norepinephrine / Q000494:pharmacology*; D010052:Ovariectomy; D011301:Preoptic Area / Q000378:metabolism* / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D016760:Proto-Oncogene Proteins c-fos; D004958:Estradiol; D009638:Norepinephrine